Introduction
HIV infection disrupts cytokine production and function of the CD4+ T helper and CD8+ cytotoxic T cells with disease progression mainly associated with a Th2 cytokine profile despite some contradictory references [1] [2] [3] . Tumor necrosis factor alpha (TNF-a), interferon gamma (IFN-g), IL-1, IL-2, , , IL-6 and IL-10 are some of the cytokines affected during HIV infection. Measuring these cytokines gives an indication of the degree of immune activation (elevated levels of TNF-a, IL-6 and IL-1), the extent of the immune response and disease progression.
A newly defined subset of CD4 cells [4] called Th 17 cells produce, amongst others, the pro-inflammatory IL-17A [5] . Th17 cells and cytokines are associated with protection against bacterial, fungal and viral infections [4, 6] and are important for maintaining a healthy mucosa. Because HIV primarily infects CD4 cells (including the Th17 subset), infection could potentially lead to a decrease in IL-17A production [5 and reviewed in 7] leaving the affected host susceptible to opportunistic infections [5, 8] . The role of Th17 cells and cytokines in the context of HIV infection is not entirely resolved but their possible involvement as prognostic indicators, contributors to disease progression and/or as antiviral agents has been reported.
Generally, Th17 cells and cytokines are elevated during early infection [4, 9] when viral load is high but is lowered during chronic infection or in long term-non progressors [9] when viral load is low. Measuring IL-17A secretion in conjunction with other cytokines could shed light on whether this protein is influenced by or can influence other cytokine groups and also whether the behaviour of this cytokine is in line with the Th2 rather than Th1 cytokine groups during HIV-1 infection.
With the advent of faster analysis times and the possibility of obtaining more information from limited sample volumes, the potential clinical value of measuring multiple cytokines to probe immune dysfunction and immune-based diseases has gained popularity [6, 10] . Measuring cytokine alterations during HIV infection [11] [12] [13] [14] [15] [16] and other pathological states [17] [18] [19] [20] [21] is increasingly being investigated for use in predicting disease progression.
Most studies have however used univariate statistical and correlation analyses. In an investigation by Roberts et al [15] , Cox proportional hazards regression was used to show that the plasma cytokine profile can predict disease progression in an acute model of HIV infection. Kamat et al [11] applied both uni-and multivariate approaches and identified a plasma cytokine signature capable of distinguishing samples collected from HIV patients (on treatment) from uninfected controls.
While IL-17A has mainly been measured following the isolation and stimulation of PBMCs in vitro, this study measured secreted cytokine levels following natural infection.
Multiplexing technologies allowed the analysis of the Th1/Th2/Th17 cytokinome through flow cytometric detection, while multivariate analysis identified specific cytokines (affected by HIV) which were also able to distinguish between the experimental groups. Cytokinomics first coined by Clerici (2010) [22] is used here in the tradition of other 'omics' approaches to mean the measurement and statistical evaluation of the cytokinome of a particular system.
The effect of HIV on the Th1/Th2/Th17 cytokine profile using multivariate approaches, as is done in this study on the serum of clinically stable patients has not been investigated before. The ability of this group of molecules to distinguish between uninfected and infected cases has not been investigated either. The detection of a number of secreted cytokines and the application of multivariate statistics to extract information on their interactions as influenced by HIV infection, with commentary on the potential role of these molecules as biomarkers of HIV/AIDS is also presented here.
Th1/Th2/Th17 cytokines were thus collectively assayed to evaluate the potential of this group of cytokines as markers of HIV infection and disease progression in this patient group. LDA and logistic regression identified IL-6 while ANOVA identified IL-6 and IL-10 to be discriminatory for HIV infection. Using the log IL-6 and IL-10 concentrations as discriminants, a scatter plot was shown to overlap for healthier individuals but separated with disease progression. IL-17A was detected in both experimental groups and associated with the clinically stable state of the majority of the patients. Following the inclusion of patients progressing to AIDS, IL-17A was marginally lowered in the HIV+ group. Collectively, the Th1/Th2/Th17 cytokines when assessed in relation to each other serve as potential prognostic indicators in the absence of antiretroviral therapy (ART).
Materials and Methods

Ethics Approval
Ethics approval was obtained from the Faculties of Natural and Agricultural Sciences and Health Sciences of the University of Pretoria (protocols E080-506-019 and 163/2008 respectively). Table 1 .
Sample preparation
Venous blood was collected in non-EDTA vacutainers (Greiner Bio-One GmbH, Kremsmünster). Serum was removed after centrifugation at 1610 × g for 10 minutes and stored at -70 °C until use. 
Cytometric Bead Array (CBA)
Cytokine analysis was done using the Human Th1/Th2/Th17 CBA kit (BD The CBA kit itself has decreased handling steps which translates into less handling errors.
Using a commercial kit such as this with internal standards helped with standardizing the data to an extent.
Statistical Analysis
Standardization of the data
Statistical analysis was performed using IBM SPSS (version 19.0). The Cronbach alpha was calculated to judge internal consistency. The calculated value was alpha= 0.708 which is reasonable for such a diverse sample group. Cytokine concentrations of each sample were averaged and a pooled average of the HIV-and HIV+ samples log transformed to make the scales of the data more comparable.
Linear Discriminant Analysis (LDA)
Using the log-transformed cytokine concentrations, LDA was applied to classify the cases as HIV-or HIV+. Stepwise discriminant analysis was used to select the best set of cytokines for the classification during which IL-6 was identified as the best discriminatory parameter of infection.
Logistic Regression
Logistic regression is a model for the probability that an individual case belongs to a particular group. A stepwise analysis was used to select the cytokines which would best classify the two groups. IL-6 was again identified as the best parameter.
Analysis of Variance (ANOVA)
Comparison of the mean log-transformed cytokine concentrations of the HIV-and HIV+ cases was done by means of analysis of variance F-tests to establish whether or not there were significant differences between the groups. Only cases where the significance level (p-value) was less than 0.05 were considered. IL-6 and IL-10 levels were significantly different between the HIV-and HIV+ groups while IL-17A was detected in both experimental groups. The latter cytokine's levels were marginally lower in the HIV+ group.
Results and Discussion
The simultaneous analysis of multiple cytokines in one experiment was not extensively done prior to technological advances such as CBA analysis. Chemometrics which employs multivariate statistical approaches has become valuable in simplifying the analysis and interpretation of large data sets. In this study, changes in the serum Th1/Th2/Th17 cytokine profile of clinically stable ART naive individuals in the asymptomatic chronic phase of HIV infection was investigated using CBA technology and multivariate statistics.
CBA kits are supplied with standard samples and allow quantitative information to be determined for test samples. Figure S1 (see supplementary data) shows representative examples of the standard curves obtained for each cytokine (R 2 was ≥ 0.99 for all the plots shown). The MFI of test samples were fitted into the 5-parameter logistic curve-fitting equation to obtain the corresponding cytokine concentrations which were standardized to allow for further statistical processing. Because cytokines form part of a network, the profile Table 2 shows that LDA was able to correctly classify 74.6 % of cases with IL-6 selected as the best discriminatory cytokine in relation to all other cytokines measured. Also shown is the percentage of misclassified cases; 9 % (HIV-) and 48 % (HIV+). IL-6 was once again identified as the discriminatory cytokine. Although the overall percentages of correctly classified cases are similar between LDA and logistic regression, these analyses misclassified a large number of HIV+ cases (48 and 56 % respectively).
These misclassifications may be a consequence of the experimental groups presenting with closely related cytokine profiles. The HIV+ individuals thus present similar immunological profiles to the HIV-individuals making it difficult for LDA and logistic regression to distinguish between these cases with 100 % accuracy. Patient records reflecting CD4 counts in particular identified these individuals as being infected but not diagnosed as having AIDS suggesting an apparently clinically stable health condition also supported by the measured cytokines.
ANOVA showed that IL-6 and IL-10 levels were dissimilar (visual representation in Figure 1 ) and differentiated the groups from one another (p=0.001 and 0.025). The log IL-6
and IL-10 concentrations of the two groups were plotted on a scatter diagram (Figure 2 ).
Poor separation of the groups was evident and is expected because of the clinically stable condition of the majority of the patients (based on CD4 data) causing them to behave closer This suggests that as HIV infection progresses to AIDS (low CD4 counts and high viremia) the discriminatory power of cytokines are improved. These findings are supportive of the view that laboratory markers are more abnormal with advanced disease [23] . In the cohort of Kamat et al [11] samples from individuals with advanced disease (CD4 nadir < 300 cells/μl blood) having variable viral loads due to the administration of ART or lack thereof, were assayed. These were correctly classified with 80 % accuracy using unsupervised hierarchical clustering. In the present article supervised approaches were mainly used.
Similar to our findings, the HIV+ cases of Kamat et al [11] when displayed on a PCA plot could not be effectively discriminated from the uninfected controls. Biomarker levels (particularly IL-6) were mostly elevated in the viremic patients. Because the patients were in the advanced stage of the disease, the authors suspect the 80 % classification to be an overestimation.
Using metabonomics, our group showed that HIV-, HIV+ and AIDS cases on ART could be distinguished from each other based on 1 H NMR metabolic profiles even though the viral load range was large [24] . Unlike Hewer et al's [24] metabolic data, the cytokine profile measured here was biased in terms of viral load, yielding clearer separation profiles where samples representative of disease progression were included. Given the limited number of cases, those having low CD4 counts were retained in the analyses as they complied with the selection criteria for this investigation (HIV+ and treatment naive). These samples therefore provided insight into how AIDS affected cytokine changes. Where those cases having low CD4 counts were removed from the analysis, the mean concentration of IL-6 and IL-10 was still discriminatory for HIV infection although with a lower degree of significance. Similar to Jansen et al [25] , it seems that viral load is the driving force determining the extent of the immune response. Keating et al [12] also showed this influence of viral load on the extent of cytokine perturbation (cytokines were less altered when viremia was lowered through treatment).
The remaining cytokines (TNF-a, INF-g, IL-2, IL-4 and IL-17) resulted in a profile that was generally indistinguishable for the two groups. The levels of most of these cytokines were slightly more variable in the HIV+ compared to the control group. These cytokines being indistinguishable between the experimental groups is also supportive of a mostly clinically stable HIV+ cohort. IL-17A was elevated in concentration compared to all other cytokines measured (Figure 1) . Although not significantly different in concentration between the groups, it was marginally lowered in the HIV+ group. Yue et al [9] documented IL-17A to be low or undetected in the blood of HIV-individuals. This finding is in contrast to data presented here where IL-17A was detected in uninfected individuals (Figure 1, left) . In agreement with data presented here, Brenchley et al [26] detected Th17 cells and IL-17A in the peripheral blood (and gastrointestinal tract) of healthy uninfected individuals.
IL-17A is reported to be elevated soon after infection but lowered during chronic infection and in long term non-progressors [9] . That the IL-17A levels were similar between HIV-and HIV+ individuals could be supportive of the clinically stable state of the majority of patients (supported by CD4 counts). When patients progressing to AIDS were included, IL-17A levels were lowered. Literature documenting an inverse correlation between viral load, the number of Th17 cells and therefore IL-17A exists [5] . In these articles IL-17A was measured following the isolation and in vitro stimulation of cells. The sera cytokines measured in the present study are in the context of natural infection and were measured ex vivo with no activation stimulus. Th17 cells can regulate the Th1 pathway [27] and therefore the production and secretion of IL-17A may signal antiviral responses. Because the patients used in this study were clinically stable, there was no in vivo stimulus for increased cytokine production and therefore levels detected in vitro appear similar to that of negative controls. with HIV infection as well as aging [14] . Although the mean age of the HIV+ individuals was higher than that of the uninfected control group (Table 1) , age could not have served as a confounding factor since one of the HIV+ samples which clustered far away was from a younger individual (22 years of age).
In an acute model of HIV infection, Roberts et al [15] showed IL-6 and IL-10, amongst other cytokines, to be elevated. These authors also showed IL-10 to be correlated to viral load. In another South African-based study INF-g, IL-6 and IL-10 were elevated in a group of HIV-infected individuals with immune reconstitution inflammatory syndrome [16] . IL-2 and IL-6 were key cytokines elevated in simian immunodeficiency virus-infected monkeys with encephalitis [12] . These examples supports IL-6 and IL-10 levels as having a role in the immune response against HIV infection and potentially also in monitoring disease progression.
A limitation of this work however is that incomplete demographic and other patient information prevented the consideration of all potentially confounding variables. The data can however still be regarded as valid (validity here is interpreted as meaning the extent to which measurements were well-founded and accurately comparable to the actual situation during infection) since cytokines disclosed by this investigation proved to be sufficiently relevant and (in some cases) significantly (IL-6 and 10) different to be taken into account in studies on HIV infection. It is, however, noteworthy that the samples that were the most differentiated ( Figure 2 ) had low CD4 counts and high viral loads. The top most sample had a viral load in excess of 8 million copies/ml plasma. This could mean that for the chronic phase of HIV infection cytokine changes are subtle and increase or become more distinct with disease progression. Whether this is a consistent characteristic of disease progression -from chronic HIV infection to full-blown AIDS -as similarly observed for our metabonomics findings [28] will have to be addressed by more comprehensive investigations.
To conduct controlled experiments on human samples is often impractical. Cytokine responses amongst individuals having different backgrounds will vary causing a spread in the data. Such moderate to large standard deviations are evident in Figure 1 . It is also seen in a recent publication where the plasma cytokine profile of individuals was measured before and after infection [15] , which is supposedly a more controlled infection model. For the data presented in this work the Cronbach alpha was calculated to judge internal consistency. The calculated value was alpha = 0.708 which is reasonable for such a diverse sample group.
Based on the inclusion of quality controls (instrument calibration, internal standards, non HIV-infected samples), the exclusion of one major confounding factor (age) and the significant cytokines detected (which correlates well with literature), the data presented in this article is considered valid and reliable.
In conclusion, the simultaneous assessment of many cytokines through multiplexing and multivariate analysis showed minimal changes in the cytokine profile of HIV+ individuals during the asymptomatic phase of infection. This changed with the progression of HIV infection to AIDS with cytokines of statistical significance being able to classify more than 70 % of the cases correctly. Cytokinomics in addition to quantifying cytokine levels in HIV-and HIV+ samples allowed for discrimination between the experimental groups. This approach discloses information on specific cytokines as potential markers of disease progression in a group of clinically stable patients prior to ART. There is however a need for studies with higher patient numbers and perhaps with viral load as the guiding parameter where the simultaneous analysis of multiple cytokines, be it different combinations of these molecules, is evaluated to further clarify the usefulness of these molecules as biomarkers for HIV/AIDS.
